Maturation and resolution of Staphylococcus aureus skin abscess
金黄色葡萄球菌皮肤脓肿的成熟和消退
基本信息
- 批准号:MR/Y000447/1
- 负责人:
- 金额:$ 41.28万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Fellowship
- 财政年份:2024
- 资助国家:英国
- 起止时间:2024 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Staphylococcus aureus (S. aureus) infections have been estimated to cause 1.1 million deaths worldwide annually. This makes it the bacterial pathogen causing the second largest number of deaths annually, after tuberculosis (1.6 million deaths). Given failures in effective vaccine development and the rising incidence of resistant strains (e.g. MRSA), S. aureus infection remains an aggressive challenge to human health. One of the key features of S. aureus infection is the formation of abscesses; bacteria and pus-filled lesions with a fibrous capsule. These form in a broad range of tissues, from the superficial (e.g. skin) to the visceral (e.g. muscle, brain, lung, liver). S. aureus abscesses are very slow to resolve and often require surgical drainage and/or prolonged courses of intravenous antibiotics. In turn, this can lead to antibiotic resistance and additional risks (e.g. catheter-associated infection, drug toxicity and Clostridium difficile infection). The healthcare costs for adequately treating these infections can be prohibitive for health systems in developing economies. Additionally, in the developed world, these infections significantly impact marginalised communities (e.g. intravenous drug users) and frequently cause outbreaks in institutions (e.g. prisons).Despite being a common and serious form of Staphylococcal infection, the biology of abscess has been remarkably unexplored, particularly from the perspective of how the immune system co-ordinates and resolves these infections. The aim of this project is to deliver a detailed characterisation of the key steps involved in how the body naturally resolves these infections in the skin. Insights we gain from this will allow us identify new treatment targets for these difficult to treat infections, helping them resolve faster. This work ultimately aims to improve outcomes for patients and reduce our reliance on prolonged antibiotics and surgery. This work may offer additional insights for other infections causing abscess and also offer insights into mechanisms of immune resolution in the skin generally, which may have implications for the treatment of a variety of dermatological conditions.
金黄色葡萄球菌(S.金黄色葡萄球菌)感染估计每年在全世界造成110万人死亡。这使得它成为每年造成死亡人数第二多的细菌病原体,仅次于结核病(160万人死亡)。鉴于有效疫苗开发的失败和耐药菌株(如MRSA)的发病率上升,S。金黄色葡萄球菌感染仍然是对人类健康的严重挑战。S.金黄色葡萄球菌感染是脓肿的形成;细菌和脓液充满的病变具有纤维包膜。它们在广泛的组织中形成,从浅表(例如皮肤)到内脏(例如肌肉、脑、肺、肝)。S.金黄色脓肿的消退非常缓慢,并且经常需要手术引流和/或静脉内抗生素的延长疗程。反过来,这可能导致抗生素耐药性和其他风险(例如,导管相关感染、药物毒性和艰难梭菌感染)。充分治疗这些感染的医疗保健费用对发展中经济体的卫生系统来说可能是高昂的。此外,在发达国家,这些感染严重影响边缘化社区(如静脉注射吸毒者),并经常在机构(如监狱)中引起暴发。尽管脓肿是一种常见和严重的葡萄球菌感染,但其生物学特征尚未得到探索,特别是从免疫系统如何协调和解决这些感染的角度。该项目的目的是提供一个详细的特征的关键步骤涉及如何在身体自然解决这些感染的皮肤。我们从中获得的见解将使我们能够为这些难以治疗的感染确定新的治疗目标,帮助它们更快地解决。这项工作的最终目的是改善患者的结局,减少我们对长期抗生素和手术的依赖。这项工作可能为其他感染引起的脓肿提供额外的见解,也提供了对一般皮肤免疫解决机制的见解,这可能对各种皮肤病的治疗有意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew Routledge其他文献
Antimicrobial-associated harm in critical care: a narrative review
- DOI:
10.1007/s00134-020-05929-3 - 发表时间:
2020-01-29 - 期刊:
- 影响因子:21.200
- 作者:
Nishkantha Arulkumaran;Matthew Routledge;Sanmarié Schlebusch;Jeffrey Lipman;Andrew Conway Morris - 通讯作者:
Andrew Conway Morris
Matthew Routledge的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
- 批准号:82372015
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
发展双模态超分辨率全景成像技术,描绘自噬和迁移性胞吐过程中的细胞器互作网络
- 批准号:92054301
- 批准年份:2020
- 资助金额:900.0 万元
- 项目类别:重大研究计划
基于Resolution算法的交互时态逻辑自动验证机
- 批准号:61303018
- 批准年份:2013
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
高计数率环境下MRPC特性研究
- 批准号:10875120
- 批准年份:2008
- 资助金额:40.0 万元
- 项目类别:面上项目
相似海外基金
Staphylococcus aureus SPREAD (S. aureus Study of Prevalence Resistance and Environmental Dissemination)
金黄色葡萄球菌传播(金黄色葡萄球菌流行耐药性和环境传播研究)
- 批准号:
10655277 - 财政年份:2022
- 资助金额:
$ 41.28万 - 项目类别:
Combating Fosfomycin Resistance in Methicillin-Resistant Staphylococcus aureus
对抗耐甲氧西林金黄色葡萄球菌中的磷霉素耐药性
- 批准号:
10580471 - 财政年份:2022
- 资助金额:
$ 41.28万 - 项目类别:
Staphylococcus aureus SPREAD (S. aureus Study of Prevalence Resistance and Environmental Dissemination)
金黄色葡萄球菌传播(金黄色葡萄球菌流行耐药性和环境传播研究)
- 批准号:
10366417 - 财政年份:2022
- 资助金额:
$ 41.28万 - 项目类别:
Staphylococcus aureus Type 7b Secretion System assembly and regulation
金黄色葡萄球菌 7b 型分泌系统的组装和调节
- 批准号:
10507394 - 财政年份:2022
- 资助金额:
$ 41.28万 - 项目类别:
Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus
宿主脂质成分对金黄色葡萄球菌抗菌敏感性的影响
- 批准号:
10564729 - 财政年份:2022
- 资助金额:
$ 41.28万 - 项目类别:
Calprotectin modulates neutrophil function during Staphylococcus aureus infection of the heart
钙卫蛋白在心脏金黄色葡萄球菌感染期间调节中性粒细胞功能
- 批准号:
10464764 - 财政年份:2022
- 资助金额:
$ 41.28万 - 项目类别:
The Role of Eicosanoid-PPAR axis in Exacerbating Post-Influenza Staphylococcus aureus Super-infection
类花生酸-PPAR 轴在加剧流感后金黄色葡萄球菌双重感染中的作用
- 批准号:
10553714 - 财政年份:2022
- 资助金额:
$ 41.28万 - 项目类别:
Calprotectin modulates neutrophil function during Staphylococcus aureus infection of the heart
钙卫蛋白在心脏金黄色葡萄球菌感染期间调节中性粒细胞功能
- 批准号:
10573312 - 财政年份:2022
- 资助金额:
$ 41.28万 - 项目类别:
The Role of Eicosanoid-PPAR axis in Exacerbating Post-Influenza Staphylococcus aureus Super-infection
类花生酸-PPAR 轴在加剧流感后金黄色葡萄球菌双重感染中的作用
- 批准号:
10421113 - 财政年份:2022
- 资助金额:
$ 41.28万 - 项目类别:
Staphylococcus aureus Type 7b Secretion System assembly and regulation
金黄色葡萄球菌 7b 型分泌系统的组装和调节
- 批准号:
10686233 - 财政年份:2022
- 资助金额:
$ 41.28万 - 项目类别: